2nd Oct 2012 07:00
2 October 2012
China New Energy Limited
("CNE" or the "Company" or the "Group)
Total Voting Rights
In accordance with the Financial Services Authority's Disclosure and Transparency Rules, the Company hereby announces that it has 316,616,862 ordinary shares of 0.025p each in issue, each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.
The above figure of 316,616,862 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Services Authority's Disclosure and Transparency Rules.
For further information please visit the Company's website www.chinanewenergy.co.uk or contact:
China New Energy Limited | www.chinanewenergy.co.uk |
Richard Bennett | Tel: 020 7148 3148 |
Ivy Xu | Tel: +86 20 8705 9371 |
Cairn Financial Advisers LLP (NOMAD) | Tel: 020 7148 7900 |
Jo Turner / Liam Murray | |
SVS Securities plc (Joint Broker) | Tel: 020 7638 5600 |
Alex Mattey / Ian Callaway | |
Newgate Threadneedle | Tel: 020 7653 9850 |
Graham Herring/Terry Garrett/ Alex White |
About China New Energy Limited
China New Energy Limited listed on London's AIM Market in May 2011. It is a profitable and growing technology and engineering solutions provider, whose operations are based in China, for bioethanol and biobutanol projects.
Through its wholly owned subsidiary, Guangdong Zhongke Tianyuan New Energy Science and Technology Co. Ltd ("ZKTY"), CNE provides process technology, engineering designs, plant manufacturing and operational services in connection with the production of fuel ethanol, edible ethanol, biobutanol, bioacetic acid and other chemicals from agricultural plant materials and waste. CNE's activities are principally based in the PRC, however, it also provides services to overseas customers in areas including Romania, Taiwan, Russia, Thailand and Indonesia. Since its formation, ZKTY has advised on more than 90 projects with an aggregate production capacity of approximately 9.0 million tonnes per year.
ZKTY has proprietary and patented bioenergy technology, and maintains its own research and development laboratory to further develop its technology and patent portfolio. ZKTY has received international standards accreditations, including ISO 9001:2000, ISO 9001:2008 and CE marking for part of its equipment.
Related Shares:
CNEL.L